Novartis Tells Justices Judge Swap Wrongly Sunk Patent Win
Novartis Pharmaceuticals has urged the U.S. Supreme Court to undo a Federal Circuit ruling invalidating a patent on blockbuster multiple sclerosis drug Gilenya, saying the appellate court incorrectly backed out of...To view the full article, register now.
Already a subscriber? Click here to view full article